Matthew Kelsey
Stock Analyst at HC Wainwright & Co.
(0.13)
# 4,481
Out of 5,115 analysts
7
Total ratings
25%
Success rate
-26.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Kelsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Assumes: Buy | $100 | $9.50 | +952.63% | 1 | Jun 2, 2025 | |
| ACXP Acurx Pharmaceuticals | Assumes: Buy | $160 | $2.37 | +6,665.33% | 1 | May 15, 2025 | |
| DBVT DBV Technologies | Maintains: Equal-Weight | $260 → $100 | $21.61 | +362.75% | 5 | Dec 20, 2018 |
Sensei Biotherapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $100
Current: $9.50
Upside: +952.63%
Acurx Pharmaceuticals
May 15, 2025
Assumes: Buy
Price Target: $160
Current: $2.37
Upside: +6,665.33%
DBV Technologies
Dec 20, 2018
Maintains: Equal-Weight
Price Target: $260 → $100
Current: $21.61
Upside: +362.75%